Syngene [SYNGENE] vs Laurus Labs [LAURUSLABS] Detailed Stock Comparison

Syngene

NSE
Loading...

Laurus Labs

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Syngene wins in 14 metrics, Laurus Labs wins in 6 metrics, with 0 ties. Syngene appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricSyngeneLaurus LabsBetter
P/E Ratio (TTM)51.5493.49Syngene
Price-to-Book Ratio5.5110.62Syngene
Debt-to-Equity Ratio12.2360.05Syngene
PEG Ratio3.610.08Laurus Labs
EV/EBITDA24.6340.37Syngene
Profit Margin (TTM)13.61%8.58%Syngene
Operating Margin (TTM)11.44%16.90%Laurus Labs
EBITDA Margin (TTM)11.44%16.90%Laurus Labs
Return on Equity10.50%7.79%Syngene
Return on Assets (TTM)7.30%3.84%Syngene
Free Cash Flow (TTM)$3.98B$-393.50MSyngene
Dividend Yield0.39%0.18%Syngene
1-Year Return-29.70%77.07%Laurus Labs
Price-to-Sales Ratio (TTM)7.078.02Syngene
Enterprise Value$252.06B$502.39BLaurus Labs
EV/Revenue Ratio6.768.47Syngene
Gross Profit Margin (TTM)75.12%59.39%Syngene
Revenue per Share (TTM)$93$110Laurus Labs
Earnings per Share (Diluted)$12.58$9.42Syngene
Beta (Stock Volatility)0.020.33Syngene
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Syngene vs Laurus Labs Stock Performance Analysis

Loading Price Chart...

Syngene
Laurus Labs
Syngene Stock Overview | Laurus Labs Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Syngene0.17%2.26%-0.88%-1.06%-4.15%-26.13%
Laurus Labs1.65%4.09%8.92%34.14%60.14%45.41%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Syngene-29.70%14.74%14.38%300.14%305.89%305.89%
Laurus Labs77.07%73.24%199.70%841.03%841.03%841.03%

News Based Sentiment: Syngene vs Laurus Labs

Syngene

News based Sentiment: MIXED

Syngene International is making strategic moves with its US expansion to address tariff risks, but faces a projected decline in profit growth for FY26. Analyst ratings remain positive, but the mixed outlook creates a complex investment picture requiring careful monitoring of upcoming events and performance against projections.

View Syngene News Sentiment Analysis

Laurus Labs

News based Sentiment: MIXED

September showcased a significant financial turnaround for Laurus Labs, with substantial increases in revenue and profit. However, concerns about the company's high valuation and mixed analyst opinions create a complex investment picture, making it a month of both positive developments and potential risks.

View Laurus Labs News Sentiment Analysis

Performance & Financial Health Analysis: Syngene vs Laurus Labs

MetricSYNGENELAURUSLABS
Market Information
Market Cap i₹260.75B₹475.51B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i630,3281,067,840
90 Day Avg. Volume i870,2342,466,961
Last Close₹649.50₹895.20
52 Week Range₹599.55 - ₹960.60₹427.05 - ₹922.50
% from 52W High-32.39%-2.96%
All-Time High₹960.60 (Dec 02, 2024)₹922.50 (Jul 30, 2025)
% from All-Time High-32.39%-2.96%
Growth Metrics
Quarterly Revenue Growth0.11%0.31%
Quarterly Earnings Growth0.15%12.03%
Financial Health
Profit Margin (TTM) i0.14%0.09%
Operating Margin (TTM) i0.11%0.17%
Return on Equity (TTM) i0.11%0.08%
Debt to Equity (MRQ) i12.2360.05
Cash & Liquidity
Book Value per Share (MRQ)₹117.59₹82.94
Cash per Share (MRQ)₹34.82₹2.67
Operating Cash Flow (TTM) i₹5.00B₹4.13B
Levered Free Cash Flow (TTM) i₹4.96B₹3.58B
Dividends
Last 12-Month Dividend Yield i0.39%0.18%
Last 12-Month Dividend i₹2.50₹1.20

Valuation & Enterprise Metrics Analysis: Syngene vs Laurus Labs

MetricSYNGENELAURUSLABS
Price Ratios
P/E Ratio (TTM) i51.5493.49
Forward P/E i38.4837.68
PEG Ratio i3.610.08
Price to Sales (TTM) i7.078.02
Price to Book (MRQ) i5.5110.62
Market Capitalization
Market Capitalization i₹260.75B₹475.51B
Enterprise Value i₹252.06B₹502.39B
Enterprise Value Metrics
Enterprise to Revenue i6.768.47
Enterprise to EBITDA i24.6340.37
Risk & Other Metrics
Beta i0.020.33
Book Value per Share (MRQ) i₹117.59₹82.94

Financial Statements Comparison: Syngene vs Laurus Labs

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)SYNGENELAURUSLABS
Revenue/Sales i₹8.75B₹15.70B
Cost of Goods Sold i₹2.18B₹6.37B
Gross Profit i₹6.57B₹9.32B
Research & Development iN/AN/A
Operating Income (EBIT) i₹1.00B₹2.65B
EBITDA i₹2.24B₹3.93B
Pre-Tax Income i₹1.01B₹2.24B
Income Tax i₹146.00M₹631.40M
Net Income (Profit) i₹867.00M₹1.62B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)SYNGENELAURUSLABS
Cash & Equivalents i₹3.67B₹995.40M
Total Current Assets i₹22.87B₹43.32B
Total Current Liabilities i₹13.96B₹35.40B
Long-Term Debt i₹4.09B₹7.08B
Total Shareholders Equity i₹47.27B₹46.03B
Retained Earnings i₹38.82B₹36.26B
Property, Plant & Equipment i₹27.42B₹1.89B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)SYNGENELAURUSLABS
Operating Cash Flow i₹2.17BN/A
Capital Expenditures i₹-680.00MN/A
Free Cash Flow i₹1.27BN/A
Debt Repayment i₹0N/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSYNGENELAURUSLABS
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i630,3281,067,840
Average Daily Volume (90 Day) i870,2342,466,961
Shares Outstanding i401.37M539.25M
Float Shares i175.53M362.33M
% Held by Insiders i0.53%0.32%
% Held by Institutions i0.32%0.32%

Dividend Analysis & Yield Comparison: Syngene vs Laurus Labs

MetricSYNGENELAURUSLABS
Last 12-Month Dividend i₹2.50₹1.20
Last 12-Month Dividend Yield i0.39%0.18%
3-Year Avg Annual Dividend i₹1.25₹1.33
3-Year Avg Dividend Yield i0.14%0.16%
3-Year Total Dividends i₹3.75₹4.00
Ex-Dividend DateJun 27, 2025May 09, 2025